Howard Goodall
Impact in
- Ophthalmology top 5%
- Ocular Oncology and Treatments
-
- Immunotherapy and Immune Responses
Papers in
-
- Ocular Oncology and Treatments 10
-
- Immunotherapy and Immune Responses 8
- Co-authors
- Richard D. Carvajal (6 shared papers)Bertil Damato (1 shared paper)Joseph Dukes (1 shared paper)Julie Glanville (1 shared paper)Shaad E. Abdullah (6 shared papers)Alexander N. Shoushtari (7 shared papers)Kelly Fleetwood (1 shared paper)Marcus O. Butler (5 shared papers)
- Journals
- Journal of Clinical Oncology (5 papers)Annals of Oncology (2 papers)Cancer Research (2 papers)Cancers (1 paper)Value in Health (1 paper)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Howard Goodall
11 papers receiving 203 citations
Peers
Comparison fields: 5 of 33
- Ophthalmology 118
- Immunology 119
- Oncology 111
- Radiology, Nuclear Medicine and Imaging 53
- Hematology 15
Countries citing papers authored by Howard Goodall
This map shows the geographic impact of Howard Goodall's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howard Goodall with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howard Goodall more than expected).
Fields of papers citing papers by Howard Goodall
This network shows the impact of papers produced by Howard Goodall. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howard Goodall. The network helps show where Howard Goodall may publish in the future.
Co-authors
The 25 scholars most cited alongside Howard Goodall, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 105 | |
| 2 | 2020 | 24 | |
| 3 | 2018 | 22 | |
| 4 | 2023 | 14 | |
| 5 | 2021 | 13 | |
| 6 | 2021 | 8 | |
| 7 | 2022 | 8 | |
| 8 | 2021 | 8 | |
| 9 | 2023 | 4 | |
| 10 | 2023 | 4 | |
| 11 | 2021 | 3 |
About Howard Goodall
Howard Goodall is a scholar working on Ophthalmology, Immunology, Oncology, Biomedical Engineering and Surgery, having authored 11 papers that have together received 213 indexed citations. Recurring topics across this work include Ocular Oncology and Treatments (10 papers), Immunotherapy and Immune Responses (8 papers), Nanoplatforms for cancer theranostics (3 papers), Cancer Immunotherapy and Biomarkers (3 papers), CAR-T cell therapy research (2 papers), Prostate Cancer Treatment and Research (1 paper), Prostate Cancer Diagnosis and Treatment (1 paper) and Protein Degradation and Inhibitors (1 paper). The work is most often cited by research in Ophthalmology (118 citations), Immunology (119 citations), Oncology (111 citations), Radiology, Nuclear Medicine and Imaging (53 citations) and Hematology (15 citations). Howard Goodall has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Richard D. Carvajal, Bertil Damato, Joseph Dukes, Julie Glanville, Shaad E. Abdullah, Alexander N. Shoushtari, Kelly Fleetwood, Marcus O. Butler, Mick Arber and Rachael McCool. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Cancer Research, Cancers and Value in Health.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.